Briacell Therapeutics Corp (BCTX)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$3.72

+0.03 (+0.81%)

Market Cap: $32.10M

Last updated: Oct 16, 2026 at 1:54 PM ET

Earnings

Performance (10Y)

Beat Rate

53%(9/17)

Avg Surprise

-4.71%

Streak

1 Q

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Apr 30, 2026Apr 26 Reported Jun 9, 2026Reported Jun 9	$-0.99	N/A	-	N/A	Beat	-	-	+94.0%
Jan 31, 2026Jan 26 Reported Mar 10, 2026Reported Mar 10	$-2.58	$-4.84	$-4.84 - $-4.84	+46.75%	Beat	1	No revisions (30d)	-10.6%
Oct 31, 2025Oct 25 Reported Dec 11, 2025Reported Dec 11	$-4.35	$-3.28	$-3.28 - $-3.28	-32.66%	Miss	1	No revisions (30d)	+86.8%
Jul 31, 2025Jul 25 Reported Oct 27, 2025Reported Oct 27	$0.04	N/A	-	+100.33%	Beat	1	1 0 30d	+157.1%
Apr 30, 2025Apr 25 Reported Jun 16, 2025Reported Jun 16	$-16.40	$-17.60	$-17.60 - $-17.60	+6.82%	Beat	0	No revisions (30d)	-199.4%
Jan 31, 2025Jan 25 Reported Mar 12, 2025Reported Mar 12	$-2.33	$-1.94	$-1.94 - $-1.94	-20.10%	Miss	0	No revisions (30d)	+97.8%
Oct 31, 2024Oct 24 Reported Dec 16, 2024Reported Dec 16	$-33.00	$-12.00	$-12.00 - $-12.00	-175.00%	Miss	0	No revisions (30d)	-161.1%
Jul 31, 2024Jul 24 Reported Oct 23, 2024Reported Oct 23	$-0.07	N/A	-	+84.78%	Beat	1	No revisions (30d)	+53.3%
Apr 30, 2024Apr 24 Reported Jun 14, 2024Reported Jun 14	$16.50	N/A	-	+120.00%	Beat	1	No revisions (30d)	+134.4%
Jan 31, 2024Jan 24 Reported Mar 18, 2024Reported Mar 18	$-106.50	$-30.00	$-30.00 - $-30.00	-255.00%	Miss	1	No revisions (30d)	+7.8%
Oct 31, 2023Oct 23 Reported Dec 14, 2023Reported Dec 14	$54.00	$-27.00	$-27.00 - $-27.00	+300.00%	Beat	1	No revisions (30d)	+614.3%
Jul 31, 2023Jul 23 Reported Oct 25, 2023Reported Oct 25	$-0.15	N/A	-	+61.54%	Beat	2	No revisions (30d)	+85.3%
Apr 30, 2023Apr 23 Reported Jun 14, 2023Reported Jun 14	$-48.00	$-53.25	-	+9.86%	Beat	-	-	+0.0%
Jan 31, 2023Jan 23 Reported Mar 15, 2023Reported Mar 15	$-115.50	$-53.25	$-53.25 - $-53.25	-116.90%	Miss	0	No revisions (30d)	-220.8%
Oct 31, 2022Oct 22 Reported Dec 14, 2022Reported Dec 14	$-10.50	N/A	-	+78.79%	Beat	0	No revisions (30d)	-6462.5%
Jul 31, 2022Jul 22 Reported Oct 27, 2022Reported Oct 27	$-1.02	$-0.35	$-0.35 - $-0.35	-191.43%	Miss	1	No revisions (30d)	-101.1%
Apr 30, 2022Apr 22 Reported Jun 13, 2022Reported Jun 13	$-48.00	$-31.50	$-31.50 - $-31.50	-52.38%	Miss	1	No revisions (30d)	-9.8%
Jan 31, 2022Jan 22 Reported Mar 15, 2022Reported Mar 15	$-36.00	$-24.75	$-24.75 - $-24.75	-45.45%	Miss	1	No revisions (30d)	+49.5%
Oct 31, 2021Oct 21 Reported Dec 14, 2021Reported Dec 14	$-0.16	N/A	-	N/A	Beat	-	-	+99.8%
Apr 30, 2021Apr 21 Reported Jun 29, 2021Reported Jun 29	$91.03	N/A	-	N/A	Beat	-	-	+186.0%
Jan 31, 2021Jan 21 Reported Mar 31, 2021Reported Mar 31	$-43.71	N/A	-	N/A	Beat	-	-	+85.3%
Oct 31, 2020Oct 20 Reported Oct 31, 2020Reported Oct 31	$-71.24	N/A	-	N/A	Beat	-	-	-3805.3%
Jul 31, 2020Jul 20 Reported Jul 31, 2020Reported Jul 31	$-105.72	N/A	-	N/A	Beat	-	-	+63.8%
Apr 30, 2020Apr 20 Reported Apr 30, 2020Reported Apr 30	$-105.79	N/A	-	N/A	Beat	-	-	+62.4%
Jan 31, 2020Jan 20 Reported Apr 30, 2020Reported Apr 30	$-297.18	N/A	-	N/A	Beat	-	-	+9.5%
Oct 31, 2019Oct 19 Reported Oct 31, 2019Reported Oct 31	$-1.82	N/A	-	N/A	Beat	-	-	+99.2%
Jul 31, 2019Jul 19 Reported Jul 31, 2019Reported Jul 31	$-292.34	N/A	-	N/A	Beat	-	-	+37.2%
Apr 30, 2019Apr 19 Reported Apr 30, 2019Reported Apr 30	$-281.08	N/A	-	N/A	Beat	-	-	+39.5%
Jan 31, 2019Jan 19 Reported Apr 30, 2019Reported Apr 30	$-328.33	N/A	-	N/A	Beat	-	-	-6.1%
Oct 31, 2018Oct 18 Reported Oct 31, 2018Reported Oct 31	$-225.64	N/A	-	N/A	Beat	-	-	-8.7%
Jul 31, 2018Jul 18 Reported Jul 31, 2018Reported Jul 31	$-465.55	N/A	-	N/A	Beat	-	-	-21.8%
Apr 30, 2018Apr 18 Reported Apr 30, 2018Reported Apr 30	$-464.88	N/A	-	N/A	Beat	-	-	-19.8%
Jan 31, 2018Jan 18 Reported Jan 31, 2018Reported Jan 31	$-309.40	N/A	-	N/A	Beat	-	-	-121.1%
Oct 31, 2017Oct 17 Reported Oct 31, 2017Reported Oct 31	$-207.67	N/A	-	N/A	Beat	-	-	-27.0%
Jul 31, 2017Jul 17 Reported Jul 31, 2017Reported Jul 31	$-382.27	N/A	-	N/A	Beat	-	-	-
Apr 30, 2017Apr 17 Reported Apr 30, 2017Reported Apr 30	$-387.91	N/A	-	N/A	Beat	-	-	-
Jan 31, 2017Jan 17 Reported Apr 30, 2017Reported Apr 30	$-139.93	N/A	-	N/A	Beat	-	-	-
Oct 31, 2016Oct 16 Reported Oct 31, 2016Reported Oct 31	$-163.55	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.47	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-175.30%	ROIC	N/A
Financial Health
Debt/Equity	N/A	Interest Coverage	N/A
Current Ratio	7.07x	Quick Ratio	7.07x
Trading Statistics
Beta	1.51	Avg Volume	128.58K
52-Week High	$14.68	52-Week Low	$2.60

Technical Indicators Dashboard

Moving Averages

SMA 10$3.91

SMA 20$4.04

SMA 50$3.80

SMA 200$4.03

EMA 10$3.87

EMA 20$3.91

EMA 50$3.83

EMA 200$5.86

MACD

Line: -0.01Signal: 0.05Hist: -0.06

ADX

ADX: 21.9+DI: 15.3-DI: 18.0

Aroon & PSAR

Aroon Up40.0

Aroon Down12.0

PSAR$4.23

Bollinger Bands

Upper Band$4.41

Lower Band$3.66

%B Position1861%(Upper)

Band Width0.08

RSI (14-Day)

Neutral

43.0

Momentum Oscillators

Stoch %K3.2

Stoch %D2.6

Williams %R-93.2

ROC (10d)-9.5%

Momentum-0.39

CCI (20d)-155.4

MFI (14d)7.9

Volatility Measures

ATR (14d)$0.22(6.0%)

StdDev (20d)0.19

Hist Vol45.6%(High)

Volume Flow

VWAP$3.74

OBV8.7M

AD Line20.0B

CMF (20d)-0.118

Volume Metrics

Avg Vol (20d)112.8K

Vol Ratio0.3x(Low)

VWMA (20d)$4.12

Pivot Points

R3$4.04

R2$3.96

R1$3.82

Pivot Point$3.75

S1$3.61

S2$3.54

S3$3.40

Advanced Oscillators

TSI-1.51

Ultimate Osc27.4

KST52.66

Financial Data

Quarter	Apr 2026	Jan 2026	Oct 2025	Jul 2025	Apr 2025	Jan 2025	Oct 2024	Jul 2024	Apr 2024	Jan 2024	Oct 2023	Jul 2023
Total Revenue	$0	$0	$0	$225,340	$0	$0	$0	$22,671	$0	$0	$0	$0
Cost of Revenue	$0	$27,140	$0	$36,427	$0	$0	$0	$71,849	$0	$0	$0	$3,861
Gross Profit	$0	$-27,140	$0	$-36,427	$0	$0	$0	$-71,849	$0	$0	$0	$-3,861

Operating Expenses	$7.62M	$7.64M	$8.32M	$8.55M	$6.33M	$7.17M	$5.15M	$5.77M	$9.23M	$9.83M	$8.50M	$7.71M
R&D	$5.97M	$8.26M	$6.68M	$7.11M	$4.81M	$5.68M	$3.67M	$4.41M	$7.66M	$8.26M	$6.86M	$5.17M
SG&A	$1.65M	$2.02M	$1.64M	$1.44M	$1.52M	$1.48M	$1.49M	$1.36M	$1.57M	$1.57M	$1.65M	$2.54M
Operating Income	$-7,620,794	$-7,668,006	$-8,322,943	$-8,554,273	$-6,328,255	$-7,169,443	$-5,152,832	$-5,767,954	$-9,229,648	$-9,829,446	$-8,503,028	$-7,705,761

Interest Income	$0	$105,638	$-44,830	$0	$-62,738	$-42,584	$-71,515	$-51,168	$-36,997	$-18,345	$0	$0
Interest Expense	$0	$0	$0	$0	$0	$0	$676,444	$0	$0	$1.50M	$0	$0
Income Before Tax	$-7,172,752	$-7,429,378	$-8,278,328	$-8,223,908	$-6,224,929	$-6,337,828	$-5,829,276	$-1,248,752	$1.69M	$-11,333,910	$5.96M	$-2,418,655
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-7,237,055	$-7,352,942	$-8,278,328	$-8,164,107	$-6,224,929	$-6,337,828	$-5,829,276	$-1,248,752	$1.69M	$-11,333,910	$5.96M	$-2,418,655

EBITDA	$-7,172,752	$-7,640,866	$-8,206,841	$-8,093,632	$-6,146,988	$-6,264,769	$-5,731,104	$-1,140,411	$1.73M	$-11,307,928	$5.96M	$-2,430,108
EBIT	$-7,172,752	$-7,668,006	$-8,233,498	$-8,105,018	$-6,162,191	$-6,295,244	$-5,757,761	$-1,197,584	$1.73M	$-11,315,565	$5.96M	$-2,418,655

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about BCTX

News

BriaCell Therapeutics Corp Financial Disclosures & Filings

This article provides a list of financial disclosures and regulatory filings for BriaCell Therapeutics Corp (BCT) on the Toronto Stock Exchange. It details quarterly and annual earnings reports from FY2021 to FY2026...

TradingView•Oct 6, 2026 1:25 PM ET10/6/26•Somewhat-Bullish

BriaCell Therapeutics Corp Warrant - on BriaCell Therapeutics Financial Disclosures & SEC Filings

This page provides access to BriaCell Therapeutics Corp.'s SEC filings and other financial documents, including Forms 10-K, 10-Q, and earnings reports. It covers filings from 2021 through 2026...

TradingView•Oct 5, 2026 8:40 AM ET10/5/26•Somewhat-Bullish

BriaCell Therapeutics Corp Financial Disclosures & SEC Filings

This article provides a list of SEC filings and financial disclosures for BriaCell Therapeutics Corp. (BCTX), detailing their earnings reports and annual reports from 2021 to 2026. The summaries highlight key financial...

TradingView•Oct 1, 2026 5:52 AM ET10/1/26•Somewhat-Bullish

BriaCell Therapeutics Corp. (TSX:BCT) Gains 5.17% as Phase 3 Progress and Expanding Cancer Pipeline Support Sentiment

BriaCell Therapeutics Corp. (TSX:BCT) saw its shares rise by 5.17% on September 30, 2026, driven by positive investor sentiment regarding its developing cancer immunotherapy platform. The company's lead Bria-IMT program...

kalkine.ca•Oct 1, 2026 1:10 AM ET10/1/26•Neutral

BriaCell Therapeutics Corp. (TSX:BCT): Immunotherapy Pipeline Progress and Clinical Momentum Drive Renewed Investor Confidence

BriaCell Therapeutics Corp. (TSX:BCT) is a clinical-stage biotechnology company focused on developing immunotherapies for cancer. The stock rose 6.36% on September 24, 2026...

kalkine.ca•Sep 26, 2026 1:53 AM ET9/26/26•Neutral

BCTX Valuation and Fair Value

P/E: -0.5x
P/B: 1.1x

See GNG's fair value

BCTX Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROE: -175.3%

BCTX Competitors

Company	Ticker
Quince Therapeutics, Inc.	QNCX
Rockwell Medical Inc	RMTI
China Pharma Holdings Inc	CPHI
CEL-SCI Corp	CVM
Elutia Inc.	ELUT
Milestone Scientific	MLSS
NanoViricides Inc	NNVC
Actinium Pharmaceuticals Inc	ATNM

Sector: Healthcare

BCTX Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: 19.5%

Frequently Asked Questions About BCTX

Does BCTX pay dividends?

Briacell Therapeutics Corp (BCTX) does not currently pay a regular dividend.

What is BCTX's market cap?

Briacell Therapeutics Corp (BCTX) has a market capitalization of $32.10M with a current stock price of $3.72.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In